Wave Life Sciences Files DEFA14A Proxy Materials
Ticker: WVE · Form: DEFA14A · Filed: Apr 15, 2026 · CIK: 0001631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | DEFA14A |
| Filed Date | Apr 15, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-governance
TL;DR
Wave Life Sciences filed proxy docs, nothing major revealed yet.
AI Summary
Wave Life Sciences Ltd. filed a Definitive Additional Materials (DEFA14A) on April 15, 2026. This filing is related to proxy materials and does not contain specific financial figures or operational updates within the provided text. The filing is primarily procedural, concerning the solicitation of proxies.
Why It Matters
This filing indicates procedural steps in corporate governance, potentially related to upcoming shareholder votes or decisions, though specific details are not in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard DEFA14A, which is procedural and does not inherently carry significant financial risk based on the provided information.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Filer of the DEFA14A
- 0001631574 (company) — CIK number for Wave Life Sciences Ltd.
- 0001193125-26-157014 (filing_id) — SEC Accession Number for the filing
- 2026-04-15 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which stands for Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
Who is the filer of this document?
The filer is Wave Life Sciences Ltd., with CIK number 0001631574.
When was this filing submitted to the SEC?
The filing date was April 15, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001193125-26-157014.
What are the mailing and business addresses listed for Wave Life Sciences Ltd.?
The mailing address is 733 CONCORD AVENUE CAMBRIDGE MA 02138, and the business address is 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 15, 2026 regarding Wave Life Sciences Ltd. (WVE).